Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001746473-26-000054

Options or other derivatives

  • Chief Financial Officer acquired 592,495 shares (grant or award)
  • Chief Financial Officer returned 592,495 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Returned to the company · Stock Option (Right to Buy) −76,047 0 D: show line 1 in the form
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Grant or award · Stock Option (Right to Buy) +76,047 76,047 D: show line 2 in the form
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Returned to the company · Stock Option (Right to Buy) −18,198 0 D: show line 3 in the form
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Grant or award · Stock Option (Right to Buy) +18,198 18,198 D: show line 4 in the form
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Returned to the company · Stock Option (Right to Buy) −74,250 0 D: show line 5 in the form
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Grant or award · Stock Option (Right to Buy) +74,250 74,250 D: show line 6 in the form
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Returned to the company · Stock Option (Right to Buy) −124,000 0 D: show line 7 in the form
Cummings Keith Lamont Chief Financial Officer 2026-04-17 Grant or award · Stock Option (Right to Buy) +124,000 124,000 D: show line 8 in the form
Loading xslF345X06/wk-form4_1776458561.xml…